With the advent of the monoclonal antibody trastuzumab over 2 decades ago for breast cancer therapy, the outcome of patients with human epidermal growth factor receptor (HER) 2-positive disease has improved dramatically. Based on its substantial efficacy and good tolerability, trastuzumab has become ...
Metastasis is the leading cause of death in breast cancer patients. For metastasis to occur, tumor cells must invade locally, intravasate, and colonize distant tissues and organs, all steps that require tumor cell migration. The majority of studies on in
It involves metastatic triple negative breast cancer (mTNBC) patients. This analysis focused on the long-term positive survival impact of treatment with trilaciclib in combination with cytotoxic chemotherapy (gemcitabine/carboplatin; GCb). The results were showcased at the 2023 San Antonio Breast ...
PHILADELPHIA (CBS) – A Philadelphia woman living with Stage 4 metastatic breast cancer is not letting a dire diagnosis stop her from living her best life. Jamil Rivers has become a national spokesperson through her work with Susan G. Komen to shed light on the metastatic breast cancer communit...
“With this agreement, we have laid the foundation for our potentially best-in-class oncology pipeline,” said Athena Countouriotis, M.D., co-founder, president and CEO of Avenzo. “Patients with HR+/HER2- metastatic breast cancer continue to have limited therapeutic options, and we believe...
LTBP3 promotes early metastatic events during cancer cell dissemination Elena I. Deryugina Ewa Zajac James P. Quigley Article19 Jan 2018Oncogene How asbestos drives the tissue towards tumors: YAP activation, macrophage and mesothelial precursor recruitment, RNA editing, and somatic mutations ...
If you currently have cancer, you might still be eligible for a no-waiting period policy if it’s stage one or less. Assuming there has not been a previous instance of cancer or metastatic cancer, the following cancers are eligible for immediate coverage if it’s stage 0-1: Breast Cervica...
The article provides information on a study which examined the efficacy of Abraxane or paclitaxel in comparison with Taxotere or docetaxel in the first-line treatment of metastatic breast cancer. The data of the study was presented at the 29th Annual San Antonio Breast Cancer Symposium in San ...
Metastatic Breast Cancer Symposium: From Biology to Therapeutic Strategies: How to best assess response: Blood-based testsPierga, JeanYves
Discusses research being done on the cost-effectiveness of the drugs anastrozole and exemestane for the treatment of metastatic breast cancer. Reference to a study by S. Verma and A. Rocchi published in the November 2003 issue of "Supportive Care in Cancer" journal; Medical costs associated with...